To Evaluate the Efficacy and Safety of Co-administrated HODO-2224-1 and HODO-2224-2 in Patients With Essential Hypertension and Primary Hypercholesterolemia

计划入组 125 人 · 首次发布于 2024 年 10 月 17 日

A Clinical Study Aiming to Validate the Equipment: VoluSense Pediatrics (VSP)

计划入组 50 人 · 首次发布于 2016 年 3 月 4 日

Clinical Study of Peripheral Capillary Oxygen Saturation (SpO2): Vital Signs Patch (VSP)

计划入组 12 人 · 首次发布于 2013 年 7 月 16 日

HODO-2224

VSP-77

VSP-17

VISION SERVICE PLAN

United States

KEY THERAPEUTICS, LLC

United States

Invesco BulletShares 2024 Municipal Bond ETF

Vgenomics Partners with Dr. Shroff's Eye Hospital to Validate AI-Powered Tear Biomarker for Early Keratoconus Detection

ASCO 2024: Experts Debate Neoadjuvant Therapy vs. Surgery in NSCLC

Fecal Microbiota Transplant Enhances Immunotherapy Response in Metastatic Renal Cell Carcinoma